Frequency Therapeutics’ hearing loss treatment showed early signs of efficacy last year, with some patients showing improvements after a few months. Now, as the biotech plugs away at a phase 2a study, ...

WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused ...

Ask An Audiologist has published a new guide explaining normal hearing range Hz by age, helping readers understand how hearing changes gradually and what frequency-based hearing tests actually reveal.

Astellas Pharma will partner with Frequency Therapeutics to develop Frequency’s lead candidate—the Phase IIa-bound sensorineural hearing loss regenerative therapeutic FX-322—through a collaboration ...

Concertgoers, rejoice: An early safety study of Frequency Therapeutics’ hearing loss drug treatment has cleared its first hurdles while showing some signs of hearing improvement in certain patients.

Shape matters, even in hearing. Specifically, it is the shape of the cochlea -- the snail-shell-shaped organ in the inner ear that converts sound waves into nerve impulses that the brain deciphers -- ...

The genetics responsible for frequency-specific hearing loss have remained elusive until recently, when genetic loci were found that affected high-frequency hearing. Now, a study reports, for the ...

An experimental regenerative therapy that Frequency Therapeutics was developing to treat a form of hearing loss has failed to beat a placebo in a clinical trial for the second time in two years, ...